• Login as Editor
    View Item 
    •   Yeshiva Academic Institutional Repository
    • Albert Einstein College of Medicine (AECOM)
    • Albert Einstein College of Medicine: Doctoral Dissertations
    • View Item
    •   Yeshiva Academic Institutional Repository
    • Albert Einstein College of Medicine (AECOM)
    • Albert Einstein College of Medicine: Doctoral Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Contributions of autonomic nerves to exocrine malignancies: A focus on adrenergic signals in prostate cancer progression

    Thumbnail

    Date
    2017
    Author
    Zahalka, Ali H.
    Metadata
    Show full item record
    Share
    Abstract
    Just as autonomic nerves pattern exocrine gland development, malignancies arising from these glands (including pancreatic, breast, and prostate) co-opt neural programs to promote their growth and progression. Animal models of exocrine tumorigenesis in combination with clinical data suggest that adrenergic nerves promote exocrine malignancies through beta-adrenergic signaling in the tumor microenvironment. Since nerves closely associate with blood vessels, patterning the vasculature during development, we explored the contributions of adrenergic nerves and signals to the endothelium in prostate cancer. Here, we show that loss of beta-adrenergic receptor signaling in the prostate stroma inhibits tumor growth by altering endothelial metabolism, turning off the angiogenic switch that enables exponential tumor growth. While endothelial cells rely on anaerobic glycolysis for vessel formation, loss of endothelial Adrb2 (the gene encoding the beta2-adrenergic receptor) inhibits angiogenesis by shifting metabolism to oxidative phosphorylation. Co-deletion of Adrb2 and Cox10, a cytochrome IV oxidase assembly factor, prevented this metabolic shift and rescued angiogenesis and cancer progression. These results thus suggest that adrenergic nerves mediate a pro-angiogenic switch during the early stages of prostate carcinogenesis, and abrogation of beta-adrenergic signaling inhibits the angiometabolic switch and delays cancer progression. Since exocrine glands such as the pancreas and breast may exhibit a similar developmental and malignant dependency on adrenergic signals, targeting the cross-talk between nerves and endothelial metabolism may serve as a novel anti-cancer therapeutic strategy.
    Permanent Link(s)
    https://ezproxy.yu.edu/login?url=http://gateway.proquest.com/openurl?url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation&res_dat=xri:pqm&rft_dat=xri:pqdiss:10742220
    https://hdl.handle.net/20.500.12202/476
    Citation
    Source: Dissertation Abstracts International, Volume: 79-02(E), Section: B.;Advisors: Paul S. Frenette.
    *This is constructed from limited available data and may be imprecise.
    Collections
    • Albert Einstein College of Medicine: Doctoral Dissertations [1674]

    Yeshiva University Libraries copyright © 2021  DuraSpace
    YAIR Self-Deposit | YAIR User's Guide | Take Down Policy | Contact Us
    Yeshiva University
     

     

    Browse

    AllCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    Login as Editor

    Statistics

    View Usage Statistics

    Yeshiva University Libraries copyright © 2021  DuraSpace
    YAIR Self-Deposit | YAIR User's Guide | Take Down Policy | Contact Us
    Yeshiva University